Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platina trial of labetalol versus nifedipine for acute severe hypertension in pregnancy
NL-OMON47595Phase 3Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pregnancy-induced hypertension (PIH) and preeclampsia comparing Intravenous labetalol with Oral nifedipine (2 arms). Primary endpoint: Composite poor maternal and neonatal outcome. Started Aug 2018; status: recruiting.
02
Drugs
labetalolnifedipine
03
Conditions
pregnancy-induced hypertension (PIH)preeclampsia
Beyond the preview
Go deeper on NL-OMON47595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47595.